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NOTES AND COMMENTS 
C-3' Quaternary Ammonium Cephems, a New Wave 
of Cephalosporins 
Andrd Bryskier 
The new wave of C-3' quaternary ammonium cephems 
can be divided into two groups of compounds 
according to the nucleus attached to the oxi-imino 
group. All have a quaternized N-nucleus or an alkyl 
side chain attached to the methylene group at the C-3 
position in the thiazolyl ring of the cephem nucleus 
(Figure I). They belong to group IV of the micro- 
biological classification (1). This group is divided in 
group IV-A and group IV-B (Figure 2). Compounds 
belonging to group IV-B have a 5-amino-2-thia- 
diazolyl moiety. The nucleus in 'the 7-side-chain 
appears to confer a better antipseudomonal activity, 
owing mainly to reduced affinity for the I? aeruginosa 
chromosomal cephalosporinase, coupled with high 
resistance to enzymatic hydrolysis. However, this 
moiety has little effect on the activity on Escherichia coli, 
which constitutively produces only a very low level of 
cephalosporinase. Cefluprenam (E-1077) differs from 
other derivatives of group IV-B by a monofluoro- 
methoxyimino group at the 7-position. This leads to a 
two-fold increase in activity against most bacteria as 
compared with methoxi imino counterparts. 
C-3' quarternary ammonium cephalosporins are 
also affected by class I p-lactamases, but to a much 
lesser extent than cefotaxime and its derivatives. 
The difference in susceptibility appears to be related 
to membrane permeability, p-lactamase affinity and 
hydrolysis rate. All these compounds are zwitterions 
with quaternary nitrogens. The positive charge serves 
to orient the molecule at the door of cation-selective 
porin channels, while the net neutral charge allows 
the molecule to penetrate more rapidly than those 
with a net negative charge such as ceftazidime. In 
addtion these compounds have poor affinity for class 
1 6-lactamases and are more slowly hydrolysed than 
ceftazidime. The penetration rate of cefpirome and 
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cefepime through the outer membrane of Enterobacter 
cloacae is 5 to 20 times higher than that of ceftriaxone 
or cefotaxime. The rate of hydrolysis by p-lactamase 
produced by E. cloacae is more than 80 times lower than 
for cefotaxime. 
All these derivatives share, to various degrees, the 
same antibacterial activity against Enterobacteriaceae, 
including isolates producing class 1 f3-lactamases. 
They are active against I? aeruginosa. Compounds with 
a 5-amino-2-thiadiazolyl ring such as cefclidin, cefozo- 
pran, and cefluprenam are more active against I? 
aevuginosa. Cefoselis (FK 037) has activity against 
aerobic gram-negative bacilli, including I! aeruginosa, 
but without sacrificing activity against gram-positive 
cocci (see our article p. 13). Only cefpirome and 
cefluprenam show modest activity in vitro against 
E. faecalis, other derivatives being inactive. 
I t  has recently been shown that a few C-3' 
quaternary ammonium cephems (e.g. cefoselis, ceflu- 
prenam, DQ-2556, and cefozopran) have enhanced 
activity against S. aureus resistant to methicillin (2). This 
could open a new field of research on cephalosporins 
or other p-lactams which are globally considered 
to have poor affinity for penicillin binding protein 
(PBP 2'). 
Ternansky et al. (3) studied a series of carbacephems 
and found that a few compounds bearing a benzo- 
thiazole at C-3 displayed a good activity against 
heteroresistant strains and homoresistant isolates of 
S. aureus. These compounds bind to PBP 2' with ICSO 
values that correlate well with the observed MICs 
(minimum inhibitory concentrations) against resistant 
strains. 
Cefluprenam is more active than cefpirome against 
methicillin-susceptible S. aureus isolates through the 
introduction of a new chemical entity in the cephem 
puzzle: a propenyl side chain. 
All these compounds have the same pharma- 
cokinetics, with an apparent elimination half-life of 
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Cef I u p ren a m 
After 1 g i.v. the trough level at C12~ ranged from 
1 mg/l (cefclidin, cefozopran, cefluprenam) to 3 mg/l 
(cefoselis). Areas under the curve (AUCs) ranged 
between 142 mg/h/l/ (cefpirome) and 163 mg/h/l 
(cefoselis). Protein binding of these derivatives is low. 
The new wave of cephalosporins is innovative; 
all show antipseudomonal activity and now cover 
Enterobacteriaceae producing class 1 P-lactamases. 
Extended-spectrum p-lactamases such as TEM-3, 
TEM-5 and TEM-6 hydrolyse these cephems only 
Table 1 Pharmacokinetics of C-3' quaternary ammonium 
cephems. 
Urinary Protein 
C t 2 f z  T 54 AUC elimination binding 
(mg/l) (h) mg.h/l (%) w4 
Cefpirome 1.15 1.9 142.1 71 5 10 
cefepime 2.33 2.3 149.0 75.8 19 
cefclidin -1 1.9 168.8 84.3 5 10 
cefozopran -1  1.9 144.1 87.7 31 
cefoselis -3 2.3 163 97.1 16.7 
cefluprenam -1 1.9 159.2 94.7 14 
Bryskier ,  C - 3 '  Q u a t e r n a r y  A m m o n i u m  C e p h e m s ,  a N e w  W a v e  o f  C e p h a l o s p o r i n s  3 
moderately, but these compounds are less stable to 
hydrolysis by TEM-7, TEM-9, CAZ-2 and SHV 
enzymes (SHV-2 to SHV-7). Some compounds show 
good antistaphylococcal activity. 
In the chemical structure puzzle of the cephems, a 
new derivative has to possess a 2-amino-5-thiazolyl 
ring combined with a substituted a-oxi-imino side 
chain at the C-7 position of the cepheni nucleus. Other 
alterations have been suggested to expand the anti- 
bacterial spectrum and activity of the cephems, such as 
new moieties appended to the oxi-imino chain (e.g. a 
catechol nucleus) or an unsaturated chain at  C-3 
located between the methylene group (vinilog chain) 
and the C-3' quaternary ammonium moiety which 
confers improved activity against gram-positive cocci. 
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